The Potential of mRNA-based Therapeutics in the Management of Infectious Diseases

Abstract

Recent research has revealed several advantageous aspects of mRNA-based strategies that support the drug development process. mRNA-based therapeutics have become an alluring new therapeutic class that is predicted to transform the treatment of infectious diseases through different approaches. The effective production of mRNA-based COVID-19 vaccines has created exciting new prospects for the development of innovative mRNA-based medications and vaccinations to treat a number of challenging disorders. In this issue, Alkhatib (2025) talks about the latest advancements in mRNA technology beyond COVID-19 vaccinations, critically examining the difficulties and possibilities of mRNA-based treatments for other illnesses. mRNA vaccines and treatments can reach their full potential and significantly improve human health and quality of life globally with further development.